Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left">
                Patients</td><td align="center">Age (y)</td><td align="center">Type of infection</td><td align="center">Blood culture</td><td align="center">Risk factor for the event</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">1</td><td align="center">62</td><td align="center">GUI + sepsis</td><td align="center"><i>E. coli </i></td><td align="center">Advancer CVD and secondary neurologic disorder</td></tr><tr><td align="left">2</td><td align="center">71</td><td align="center">GUI + sepsis</td><td align="center"><i>E. coli </i></td><td align="center">History of prostatitis, LUTS</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>GUI: genitourinary infection; LUTS: lower urinary tract symptoms; CVD: cardiovascular disease; BTRP: transrectal prostate biopsy.<br/></td></tr></table>

Details of two patients with sepsis after BTRP.

International Scholarly Research Notices

tab2

Table 2

Table 2: Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy 